RiboNova is Drug Discovery in United States that focus on drug development business. Founded in 2013. They cover business area such as developer, small molecule drug, serious rare disease, precision medicine, acid anomaly, rare medical disease, physician, modify RNA nucleotide.
2013
( 11 years old in 2024 )
Drug Development
-
100 East Lancaster Avenue
Lankenau Institute for Medical Research R133
Wynnewood, PA 19096
United States
Private
developersmall molecule drugserious rare diseaseprecision medicineacid anomalyrare medical diseasephysicianmodify RNA nucleotide
* We use standard office opening hours in near RiboNova's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
RiboNova is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), RiboNova business is focusing on Drug Development.
RiboNova headquarter office and corporate office address is located in 100 East Lancaster Avenue Lankenau Institute for Medical Research R133 Wynnewood, PA 19096 United States.
RiboNova was founded in United States.
In 2024, RiboNova is currently focus on drug development sector.
Above is snippet of Google Trends for "drug development" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with RiboNova, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
